Laurence Lodé

2.3k citations

30 papers · 1.3k indexed · h-index 16

Hematology top 1%
- Multiple Myeloma Research and Treatments 13
- Hematopoietic Stem Cell Transplantation 5
- Acute Myeloid Leukemia Research 4
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
Oncology top 10%
- Cancer Treatment and Pharmacology 2
Molecular Biology top 10%
- Ubiquitin and proteasome pathways 4
Cancer Research
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Immunology
- Immune Cell Function and Interaction 2

Co-authors: Hervé Avet‐Loiseau Stéphane Minvielle Régis Bataille Jean‐Luc Harousseau Florence Magrangeas Philippe Moreau L. Campion Richard Garand
Cited by: Hematology Genetics Oncology
Journals: Blood (9 papers)Leukemia (4 papers)Biology of Blood and Marrow Transplantation (2 papers)
Partner nations: France United States Sweden

In The Last Decade

Laurence Lodé

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Laurence Lodé

Since Specialization

Citations

This map shows the geographic impact of Laurence Lodé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Lodé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Lodé more than expected).

Fields of papers citing papers by Laurence Lodé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Lodé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Lodé. The network helps show where Laurence Lodé may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Laurence Lodé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laurence Lodé Line = papers co-authored together Laurence Lodé links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation Transplantation ·Bruno Dabout,Catherine Willem,Christelle Volteau,Nolwenn Legrand,Patrice Chevallier,Laurence Lodé,Seung En Lee,Anne Cesbron,Marc Bonneville,Philippe Moreau,David Senitzer,Christelle Retière,Katia Gagne	2016	4
2	Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis Cancer Letters ·Chantal Bou‐Hanna,Anne Jarry,Laurence Lodé,Ingo Schmitz,Klaus Schulze‐Osthoff,Sébastien Küry,Stéphane Bezieau,Jean‐François Mosnier,Christian Laboisse	2015	38
3	Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults Biology of Blood and Marrow Transplantation ·Pierre Péterlin,Jacques Delaunay,Thierry Guillaume,Thomas Gastinne,Beatrice Mahé,Viviane Dubruille,Nicolas Blin,Amandine Le Bourgeois,Éolia Brissot,Laurence Lodé,Steven Le Gouill,Philippe Moreau,Mohamad Mohty,Patrice Chevallier	2014	10
4	Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults Experimental Hematology ·Amandine Le Bourgeois,Myriam Labopin,Thierry Guillaume,Jacques Delaunay,Yohann Foucher,Benoît Tessoulin,Florent Malard,Sameh Ayari,Pierre Péterlin,Sophie Derenne,Patrick M McEnaney,Anne Cesbron,Katia Gagne,Laurence Lodé,Hanxin Fu,Berthe‐Marie Imbert‐Marcille,Steven Le Gouill,Philippe Moreau,Mohamad Mohty,Patrice Chevallier	2014	11
5	A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets Clinical Cancer Research ·Sophia Adamia,Benjamin Haibe‐Kains,Patrick M. Pilarski,Michal Bar‐Natan,Samuel Pevzner,Hervé Avet‐Loiseau,Laurence Lodé,Sigitas Verselis,Edward A. Fox,John P. Burke,Ilene Galinsky,Ibiayi Dagogo‐Jack,Martha Wadleigh,David P. Steensma,Gabriela Motyckova,Daniel J. DeAngelo,John Quackenbush,Richard M. Stone,James D. Griffin	2013	79
6	Comparison of Outcomes after Two Standards-of-Care Reduced-Intensity Conditioning Regimens and Two Different Graft Sources for Allogeneic Stem Cell Transplantation in Adults with Hematologic Diseases: A Single-Center Analysis Biology of Blood and Marrow Transplantation ·Amandine Le Bourgeois,Catherine Mohr,Thierry Guillaume,Jacques Delaunay,Florent Malard,Marion Loirat,Pierre Péterlin,Nicolas Blin,Viviane Dubruille,Beatrice Mahé,Thomas Gastinne,Steven Le Gouill,Philippe Moreau,Mohamad Mohty,Lucie Planche,Laurence Lodé,Marie C. Béné,Patrice Chevallier	2013	16
7	Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease Blood Cancer Journal ·Laurence Lodé,Philippe Moreau,Michael D. Robson,Catherine Godon,Cyrille Touzeau,Martine Amiot,Steven Le Gouill,Marie C. Béné,Catherine Pellat‐Deceunynck	2013	3
8	New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance Laboratory Investigation ·http://lattes.cnpq.br/6127552144687091,Sumie Kazunari,Carly Bates,Emmanuelle David,Jiayue Chen,Soraya Saïagh,Sylvain Bercegeay,I.G. Bearden,Marc G. Denis,Laurence Lodé,Françoise Rédiní,Helen Exarchos,Dominique Heymann,Marie‐Françoise Heymann,Fahimeh Seyedasgari,F. Gouin,Frédéric Blanchard	2013	36
9	Minor clone provides a reservoir for relapse in multiple myeloma Leukemia ·Florence Magrangeas,Hervé Avet‐Loiseau,Wilfried Gouraud,Laurence Lodé,O. Decaux,Pascal Godmer,Laurent Garderet,Laurent Voillat,Thierry Façon,Anne Marie Stoppa,Gérald Marit,C. Hulin,Philippe Casassus,Mourad Tiab,Éric Voog,Edouard Randriamalala,K. Anderson,Philippe Moreau,Nikhil Munshi,Stéphane Minvielle	2012	83
10	A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study Leukemia ·Patrice Chevallier,Myriam Labopin,Pascal Turlure,Thomas Prébet,F. Fossati,Mathilde Hunault,Kalman Filanovsky,Pascale Cornillet‐Lefèbvre,Isabelle Luquet,Laurence Lodé,Steven Richebourg,Odile Blanchet,Nathalie Gachard,Norbert Vey,Norbert Ifrah,Nöel Milpied,Harousseau Jl,Salvatore Ingrassia,Mohamad Mohty,J. Delaunay	2011	91
11	Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma Haematologica ·Laurence Lodé,Marion Eveillard,Valérie Trichet,Thierry Soussi,Soraya Wuillème,Steven Richebourg,Florence Magrangeas,Norbert Ifrah,L. Campion,Catherine Traullé,François Guilhot,Denis Caillot,Gérald Marit,Claire Mathiot,Thierry Façon,Michel Attal,Jean‐Luc Harousseau,Philippe Moreau,Stéphane Minvielle,Hervé Avet‐Loiseau	2010	105
12	Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome Journal of Clinical Oncology ·Olivier Decaux,Laurence Lodé,Florence Magrangeas,Catherine Guérin‐Charbonnel,Wilfried Gouraud,Pascal Jézéquel,Michel Attal,Jean‐Luc Harousseau,Philippe Moreau,Régis Bataille,L. Campion,Hervé Avet‐Loiseau,Stéphane Minvielle	2008	269
13	Anomalies génétiques dans le myélome : rôle dans l'oncogenèse et implications pronostiques La Revue de Médecine Interne ·O. Decaux,Laurence Lodé,Stéphane Minvielle,Hervé Avet‐Loiseau	2007	3
14	Surface‐enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node‐negative breast cancer tumors PROTEOMICS ·Gabriel Ricolleau,Catherine Guérin‐Charbonnel,Laurence Lodé,Delphine Loussouarn,Marie‐Pierre Joalland,Ralf Bogumil,J. David Ingalls,Stéphane Minvielle,Mario Campone,R. Déporte-Féty,L. Campion,Pascal Jézéquel	2006	73
15	Facteurs pronostiques biologiques dans le myélome multiple Hématologie ·Laurence Lodé,Soraya Wuillème,Hervé Avet‐Loiseau	2005	2
16	Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma Leukemia ·Soraya Wuillème,Nelly Robillard,Laurence Lodé,Florence Magrangeas,Charles-Marie La Condamine,JL Harousseau,John H. Proffitt,Stéphane Minvielle,Hervé Avet‐Loiseau,(unknown)	2004	89
17	Genetic heterogeneity in multiple myeloma Leukemia ·Florence Magrangeas,Laurence Lodé,Soraya Wuillème,Stéphane Minvielle,Hervé Avet‐Loiseau	2004	25
18	Ploidy, as Detected by Fluorescence In Situ Hybridization, Defines Different Subgroups in Multiple Myeloma. Blood ·Hervé Avet‐Loiseau,Soraya Wuillème,Nelly Robillard,Laurence Lodé,Florence Magrangeas,Charles-Marie La Condamine,Jean‐Luc Harousseau,John H. Proffitt,Stéphane Minvielle	2004	9
19	14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia Seminars in Oncology ·Hervé Avet‐Loiseau,Richard Garand,Laurence Lodé,Nelly Robillard,Régis Bataille	2003	43
20	Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis Clinical Genetics ·Virginie Scotet,Marc De Braekeleer,M.‐P. Audrézet,Laurence Lodé,C. Verlingue,I. Quéré,Bernard Mercier,I. Duguépéroux,Halima Kagee,Elío Díez Feijóo,Philippe Parent,Claude Férec	2001	28

About Laurence Lodé

Laurence Lodé is a scholar working on Hematology, Genetics, Transplantation, Oncology and Developmental Neuroscience, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Chronic Lymphocytic Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers), Ubiquitin and proteasome pathways (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Cell Function and Interaction (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (848 citations), Genetics (209 citations), Oncology (429 citations), Molecular Biology (878 citations) and Cancer Research (125 citations). Laurence Lodé has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Hervé Avet‐Loiseau, Stéphane Minvielle, Régis Bataille, Jean‐Luc Harousseau, Florence Magrangeas, Philippe Moreau, L. Campion, Richard Garand, Pascal Jézéquel and Catherine Guérin‐Charbonnel. Their work appears in journals such as Blood, Leukemia, Biology of Blood and Marrow Transplantation, Clinical Cancer Research and PROTEOMICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact